NCT04088084View on ClinicalTrials.gov

Effects of Palmitoylethanolamide on Inner Retinal Function in Glaucoma Patients by Pattern Electroretinogram

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 9, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Glaucoma
Interventions
DIETARY_SUPPLEMENT

palmitoylethanolamide (PEA) 600 mg

PEA 600 mg was added to topical therapy

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER

NCT04088084 - Effects of Palmitoylethanolamide on Inner Retinal Function in Glaucoma Patients by Pattern Electroretinogram | Biotech Hunter | Biotech Hunter